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1  | INTRODUCTION
Vulnerability	 to	 psychiatric	 disorders	 is	 determined	 by	 the	 inter-
action	of	genetic	and	environmental	 factors1	 such	as	psychosocial	
stress	and	cannabis	consumption.	The	dysregulation	of	corticostri-
atal	 circuitries	 is	 involved	 in	 the	 pathophysiology	 of	 psychotic	
disorders.2	Psychosocial	stress	has	a	remarkable	 influence	on	cen-
tral	 nervous	 system	 (CNS)	 and	 animal	 behavior.3	When	 an	 organ-




enhances	 its	 activity,	 and	 the	 circadian	 rhythm.5	 However,	 when	





prefrontal	 cortex	 (PFC)	 due	 to	 the	 fact	 that	 these	 areas	 are	 criti-
cally	 involved	 in	social	 relationships.7,8	There	 is	a	growing	body	of	
the	 literature	 that	 suggests	 that	 glucocorticoid	 receptor(s)	 involve	
G	 protein-	dependent	 mechanisms.9	 In	 particular,	 corticostriatal	
activity	 is	modulated	 by	 a	 variety	 of	 G	 protein-	coupled	 receptors	
such	 as	 the	 cannabinoid	 CB1	 receptor,	 which	 is	 highly	 abundant	
in	 the	 CNS.10	 CB1	 receptors	 are	 the	 main	 target	 for	 endogenous	
endocannabinoids	 lipid	 signaling	 molecules	 and	 mediate	 both	
Δ9-	tetrahydrocannabinol	 (THC)	 and	 synthetic	 cannabinoid	 drugs	
pharmacological	 actions.11	 The	main	 endocannabinoids	molecules	
for	 CB1	 receptors	 are	 N-	arachidonylethanolamine	 (AEA)
12 and 
2-	arachidonoylglycerol	 (2-	AG).13 N-	arachidonoylphospatidyletha






















the	 center	 of	 the	 open	 field.	 Upon	 CB1	 activation,	 N-	oleoylethanolamide	 and	 N-	
palmitoylethanolamide,	two	AEA	congeners	that	do	not	interact	directly	with	cannabi-
noid	 receptors,	 were	 enhanced	 in	 the	 striatum.	 The	 co-administration	 with	 both	
cannabinoids	induced	an	up-regulation	of	striatal	FK506	binding	protein	5.	The	inverse	
agonist	 in	 controls	 reversed	 the	 effects	 of	 WIN55212.2	 on	 motor	 activity.	 When	







shown	 to	be	deregulated	 in	 response	 to	 stress	and	 following	synthetic	cannabinoid	
drugs	thus	could	confer	vulnerability	to	cannabis	addiction	and	psychosis.	Targeting	
the	 receptors	 of	 endocannabinoids	 and	 endocannabinoid-	like	mediators	might	 be	 a	
valuable	option	for	treating	stress-	related	neuropsychiatric	symptoms.
K E Y W O R D S
CB1,	Chrna6	and	Slc6a4,	Fkbp5,	psychosocial	stress
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The	CB1/CB2	 receptor	 agonist	WIN55212.2	 (Sigma-	Aldrich,	 Seelze,	
Germany)	 and	 the	 selective	 cannabinoid	 CB1	 receptor	 antagonist	
Rimonabant	(Sequoia	Research	Products	Ltd,	Pangbourne,	UK)	were	






2.3 | Experiment design and experimental groups
The	C57Bl6/J	male	mice	were	sorted	into	two	groups:	Those	exposed	






















the	 stress	 prediction	 factor	 in	 intruders.	 In	 contrast,	 controls	 were	





Mice	 were	 exposed	 to	 psychosocial	 stress	 or	 left	 undisturbed	
for	 21	days.	 On	 day	 21,	 they	 were	 acutely	 treated	 with	 different	
cannabinoid	 drugs	 or	 vehicle	 and	 finally	 evaluated	 by	 behavioral	
testing.	 The	 stress	 paradigm,	 the	 administration	 of	 drugs,	 and	 the	
behavioral	 assessment	 took	 place	 during	 the	 dark	 phase	 (active	
phase).	We	directed	the	behavioral	analyses	by	measuring	locomotor	
and	anxiety-	like	behavior	in	the	open-	field	(OF)	test	and	testing	also	
CNS	 activity	 and	 excitability	 by	 use	of	 the	 functional	 observational	
battery	(FOB).
2.5.1 | Functional observational battery
The	FOB	has	 been	widely	 used	 and	 adapted	 for	 general	 behavioral	
studies	in	mice.18	In	this	study,	the	FOB	test	comprised	28	parameters	
by	which	 the	 investigator	evaluated	CNS	activity	and	excitability	by	
recording	 neuromuscular	 and	 autonomic	 effects,	 and	 sensorimotor	
reactivity.	 There	 were	 four	 consecutive	 testing	 situations:	 (i)	 in	 the	
home	cage,	(ii)	in	the	observer’s	hand,	(iii)	in	the	OF,	and	(iv)	manipula-
tion	tests.	After	a	brief	assessment	in	its	home	cage,	each	mouse	was	
removed	and	handled	by	 the	observer	 to	 evaluate	 ease-	of-	removal,	




















2.6 | Brain sample collection and tissue evaluation
Animals	were	sacrificed	immediately	after	OF	task	finished,	and	brain	
tissue	was	collected	accordingly.	All	mice	were	deeply	anesthetized	
by	 intraperitoneal	 injection	of	2,2,2-	tribromoethanol	 (Sigma-	Aldrich,	
Hamburg,	Germany)	and	then	transcardially	perfused	with	cold	0.1%	
phosphate	 buffer	 saline	 (PBS).	 Finally,	 the	 PFC	 and	 the	 dorsal	 CPu	
were	 freshly	 isolated	and	 frozen	 in	 liquid	nitrogen	 for	 LC-	MS,	RNA	
seq,	and	quantitative	RT-	PCR.
2.6.1 | Extraction and measurement of AEA, 2- AG, 
OEA, and PEA levels












for	 isotopic	 dilution	 liquid	 chromatography-	atmospheric	 pressure	
chemical	 ionization-	mass	spectrometry	quantification	(LC-	APCI-	MS),	









illary	 gel	 electrophoresis	 (Bioanalyzer,	 Agilent	 Technologies,	 Santa	
Clara,	USA).














bwa,22	 and	 raw	 “hits”	per	 transcript	were	merged	genewise.	DESeq	









control.	 TaqMan	 assays	 for	mouse	Chrna6,	Slc6a4, and Fkbp5	 cDNAs	
were	 selected	 from	 validated	 and	 predesigned	 Assays-	on-	Demand	
(Applied	Biosystems,	Darmstadt,	Germany)	 and	used	 in	 real-	time	PCR	
amplifications	 to	detect	 the	expressions	of	Chrna6,	Slc6a4, and Fkbp5. 
The	 reactions	 were	 performed	 in	 triplicate	 using	 2	μL	 of	 cDNA	 in	 a	








ferences	 among	 the	 levels	of	one	 factor	were	determined	by	one-	
way	 ANOVA	 or	 Brown-	Forsythe	 test	 when	 applicable.	 Bonferroni	
or	 nonparametric	 Tamhane	 post	 hoc	 test	was	 applied	 for	 pairwise	
comparisons.	Analysis	of	simple	main	effects	was	performed	whether	
there	was	a	significant	interaction	of	the	two	main	factors.	Individual	
comparisons	were	made	using	 the	Student’s	 t	 test.	ANOVA	for	 re-
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3.1 | Effects of stress
We	revealed	a	significant	effect	of	psychosocial	stress	on	body	weight	
throughout	 the	 experimental	 period	 (F(1,	 123)	=	4.84,	 P	<	0.05).	
Indeed,	 exposure	 to	2-	week	 social	 defeat	 paradigm	 significantly	 di-
minished	 body	 weight	 (t(122)	=	2.78,	 P	<	0.01),	 which	 returned	 to	
control	 levels	 by	 the	 end	 of	 the	 stress	 period	 (Figure	1,	 panel	 A).	
Social	defeat	animals	displayed	a	pronounced	scratching	activity	(F(1,	
123)	=	4.06,	 P	<	0.05)	 (Figure	1,	 panel	 B),	 urinated	more	 frequently	




before	 Benjamini-	Hochberg	 adjustment	 (Figure	S1).	 The	 cholinergic	
receptor	nicotinic	alpha	6	(Chrna6),	as	a	candidate	gene,	was	further	






ment	 on	 total	 distance	 traveled	 (F(3,	 121)	=	8.36,	 P	<	0.001),	 dis-
tance	 traveled	 in	 center	 (F(3,	121	=	3.72,	P	<	0.05),	 rearing	 activity	
(F(3,	 121)	=	3.07,	P	<	0.05),	 PEA	 levels	 (F(3,	 17)	=	7.72,	P	<	0.01,	 in	
the	dorsal	CPu),	and	OEA	levels	(F(3,	22)	=	5.29,	P	<	0.01,	in	the	dor-
sal	CPu).	Drug	 administration	had	a	 remarkable	effect	on	 the	 rela-




the	OF,	 the	cannabinoid	agonist	WIN	decreased	 the	 total	distance	
traveled	(P	<	0.01)	(Figure	2,	panel	A)	while	the	administration	of	the	
inverse	agonist	Rim	significantly	antagonized	such	effects	(P	<	0.01)	






were	 also	 observed	 in	 their	 homecage	 by	 registering	 the	 vertical	
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vehicle	 (P	<	0.01,	 in	 the	 dorsal	 CPu)	 or	 when	 compared	 to	 either	
WIN	or	Rim	alone	(P	<	0.05,	P	<	0.01;	respectively,	in	the	dorsal	CPu)	
(Figure	2,	panel	F).







In	 an	 OF	 arena,	 repeated	 long-	term	 exposure	 to	 psychosocial	
stress	exacerbated	general	motor	activity	 following	vehicle	admin-
istration	 (Figure	3,	panel	A).	 Indeed,	 social	defeat	animals	exposed	
to	 vehicle	 traveled	 longer	 distances	 than	 their	 controls	 (P	<	0.01)	
(Figure	3,	 panel	 A).	 However,	 the	 pharmacological	 treatment	with	
WIN	reduced	the	total	distance	traveled	in	the	OF	when	compared	
to	 Rim-	treated	 animals	 under	 either	 control	 or	 stress	 conditions	
(P	<	0.01)	(Figure	3,	panel	A).	Likewise,	psychosocially	stressed	mice	
exposed	 to	 the	CB1	 agonist	WIN	 alone	 traveled	 smaller	 distances	
than	the	vehicle	group	(P	<	0.01)	(Figure	3,	panel	A).	The	administra-
tion	of	 the	 inverse	agonist	 in	controls	enhanced	the	 total	distance	












indicate	P < 0.05; P	<	0.01,	respectively.	N	=	15	for	behavioral	testing,	n	=	4	for	endocannabinoids	quantification;	n	=	5	for	whole-	genome	gene	
expression.	PFC,	prefrontal	cortex;	dorsal	CPu,	dorsal	striatum;	OF,	open	field
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(Figure	3,	 panel	A).	Upon	 long-	lasting	 effects	 of	 stress,	 coadminis-
tration	with	Rim+WIN	reduced	the	 total	distance	 traveled	 in	com-











Whole-	genome	 gene	 expression	 revealed	 10	 top	 hits	 genes	 de-







Chrna6	 in	controls	 (P	<	0.05,	 in	 the	PFC)	 (Figure	3,	panel	C)	and	also	
did	so,	but	not	significantly,	when	WIN	was	administered	 in	stressed	










nonstressed	counterparts	 (P	<	0.01,	 in	the	PFC)	(Figure	3,	panel	C).	 It	
F IGURE  3 Effects	of	repeated	exposure	to	psychosocial	stress	following	acute	cannabinoid	drugs	administration.	Data	are	expressed	as	
mean	±	SEM.	(1)	Effects on mice behavior:	In	an	open-	field	arena,	exposure	to	psychosocial	stress	exacerbated	general	motor	activity	following	
vehicle	administration	(panel	A-	B).	However,	psychosocially	stressed	mice	exposed	to	the	agonist	WIN	alone	traveled	smaller	distances	than	the	
vehicle	group	(P	<	0.01)	(panel	A).	The	administration	of	inverse	agonist	Rim	in	controls	enhanced	the	total	distance	traveled	when	compared	
to	vehicle	(P	<	0.05)	(panel	A).	(2)	Effects on endocannabinoids levels:	Controls	treated	with	Rim	alone	underwent	an	increase	in	2-	AG	levels	
when	compared	to	either	vehicle	or	Rim+WIN-	treated	mice	(P	<	0.05,	in	the	PFC)	(panel	B).	The	administration	of	the	inverse	agonist	Rim	by	
the	end	of	stress	period	reduced	the	levels	of	the	endocannabinoid	2-	AG	when	compared	to	controls	that	received	the	same	drug	treatment	








intragroup	comparisons	between	treatment	groups	in	control	or	stress	conditions.	One	or	two	symbols	indicate	P < 0.05; P	<	0.01,	respectively.	
N	=	15	for	behavioral	testing,	n	=	4	for	endocannabinoids	quantification;	n	=	5	for	whole-	genome	gene	expression.	PFC,	prefrontal	cortex;	CTR,	
control;	STS,	stress









spines.26	 Remarkably,	 dysfunctions	 in	 corticostriatal	 connectivity	
have	been	involved	in	the	pathophysiology	of	psychiatric	disorders.27 
Moreover,	 the	G	protein-	coupled	CB1	 is	 extremely	 abundant	 and	 a	
key	modulator	of	the	corticostriatal	pathways.10
4.1 | Effects of stress
After	 2	weeks	 of	 daily	 psychosocial	 stress,	 animals	 showed	 loss	 of	
body	weight	in	line	with	Iniguez	et	al.28	Our	data	revealed	that	chronic	


















discrepancies	 could	 be	 attributable	 to	 methodological	 differences	
such	as:	(i)	the	use	of	mice	rather	than	rats;	(ii)	housing	conditions	(five	
mice	to	a	cage	instead	of	just	one);	and	(iii)	the	time	at	testing,	as	here	
the	 stress	 protocol	 and	 drug	 administration	were	 performed	 during	
the	 active	phase	 (after	 8	pm)	 instead	of	 the	 sleep	phase.	 Finally,	we	
measured	an	overexpression	of	Chrna6	under	stress.	Studies	of	genetic	
linkage	reported	that	the	coding	Chrna6	region	confers	risk	to	develop	
neuropsychiatric	 disorders.34	 Likewise,	 Kimbrel	 et	al35	 reported	 that	




4.2 | Effects of drug administration







onism	 can	 also	 produce	 anxiogenic	 actions.37	 Animals	 treated	with	
Rim+WIN	showed	more	frequent	rearing	behavior	than	WIN-	treated	
animals.	 Indeed,	 cannabis	 smoke	 exposure	 induced	 lower	 rearing	








Genes PFC DS FC Stress FC Rim FC WIN q value Stress q value Rim q value WIN
Chrna6 33.8 45.6 13.5 −13.2 −15.2 6.46E-	11 0 0
Slc6a4 64.2 102.3 31.7 −34.1 −32.5 1 1 0
Ldlr 7.5 7.7 −0.2 −0.3 −0.1 0.7 0.01 1
Sdf2l1 5.6 5.3 0.5 0.5 0.2 0.002 0.02 1
Lrg1 4.1 2.5 0.5 0.7 0.5 0.1 0.02 1
Fkbp5 7.8 8.0 0.5 0.4 0.2 4.81E-	06 0.03 1
Dok3 5.2 4.9 0.4 0.5 0.1 0.1 0.03 1
Hspa5 10.7 10.8 0.3 0.3 0.2 0.01 0.05 1
Manf 7.9 7.9 0.2 0.2 0.1 0.01 0.05 1











55	 (GPR55),	 peroxisome	 proliferator-	activated	 receptor-	α	 (PPAR-	α),	








It	 is	well	 known	 that	 the	glucocorticoid	 receptor	 is	 regulated	by	
several	chaperones	and	cochaperones	including	the	FKBP5	protein.41 
In	particular,	we	found	that	the	administration	of	the	CB1	inverse	ag-
onist	 Rimonabant	 potentiated	 the	 expression	 of	 Fkbp5	 when	 com-
pared	to	the	remaining	groups.	This	is	in	agreement	with	data	showing	
that	 FKBP5	 regulates	 glucocorticoid	 receptor	 sensitivity,	 increases	
its	resistance,	and	decreases	its	efficiency	at	controlling	the	negative	
feedback	in	response	to	elevated	levels	of	corticosterone,42	whereas	
Rimonabant	 can	aggravate	 the	hyperactivity	of	 the	HPA	axis	during	
stress.43	Several	studies	attest	to	the	idea	that	FKBP5	is	crucial	for	the	
development	of	stress-	related	mental	disorders	 (44,45).	However,	 it	 is	
currently	unclear	how	the	activation	of	the	endocannabinoid	system	
through	 the	use	of	 synthetic	cannabinoid	drugs	may	 regulate	either	
Fkbp5	or	glucocorticoid	 signaling	as	pointed	out	by	Wang	et	al.46 In 
conclusion,	our	understanding	of	FKBP5	functions	is	still	 incomplete	
and	thus,	further	work	must	address	this	question.
















It	 is	 widely	 accepted	 that	 upon	 HPA	 activation,	 the	 content	 of	
endocannabinoid	 lipid	 molecules	 varies	 according	 to	 the	 duration/
type	of	 stress	 stimuli	 and	 the	brain	 structure.	We	 found	 that	 social	
defeat	 animals	 exposed	 to	vehicle	 showed	 similar	 2-	AG	 levels	 than	
their	controls	in	agreement	with.48	In	contrast,	Gorzalka	et	al49	deter-
mined	 that	 after	 chronic	 stress,	 the	 endocannabinoid	 signaling	was	











pharmacological	 blockade	of	MAGL	enzyme	has	been	 reported	 in	 a	






the	 inverse	 agonist	 Rim	 influenced	 the	 expressions	 of	 Chrna6 and 
Slc6a4	 in	 opposite	 directions,	 while	 their	 coadministration	 tended	
to	 produce	 a	 net	 null	 effect	 under	 experimentally	 induced	 psycho-







environmental	 factors	 such	as	chronic	 stress	and	acute	cannabinoid	




in	 susceptible	 individuals.	 The	 underlying	 mechanisms	 disrupted	 in	
these	disorders	are	serotonergic55 and endocannabinoid56	dependent.	
Particularly,	serotonin	release	inhibition	is	attributable	to	the	 lack	of	
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scratching	phenotype,29	while	the	use	of	synthetic	cannabinoids	drugs	
interfered	with	locomotor	activity,	rearing,	and	anxiety-	like	behavior.38 
The	 glucocorticoid	 receptor	 is	 regulated	 by	 several	 chaperones	 and	
cochaperones	including	the	FKBP5	protein41	but	also	is	influenced	by	
endocannabinoid	 system.17	Additionally,	we	demonstrated	 that	psy-
chosocially	 stressed	 animals	 displayed	 changes	 in	 the	 serotonergic	
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